Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Crohn's and Colitis Année : 2022

Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study

(1) , (2) , (3) , , (4) , (5) , (6) , (7, 8, 9) , (10) , (11) , , (12, 13) , , , , , (14, 15, 16, 17, 18) , (19) , (20) , (21)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
Fichier non déposé

Dates et versions

hal-03665876 , version 1 (12-05-2022)

Identifiants

  • HAL Id : hal-03665876 , version 1

Citer

F. Poullenot, A. Amiot, M. Nachury, S. Viennot, R. Altwegg, et al.. Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study. Journal of Crohn's and Colitis, 2022, 16 (1), pp.I362-I363. ⟨hal-03665876⟩
19 Consultations
0 Téléchargements

Partager

Gmail Facebook Twitter LinkedIn More